TFE3 and neoplasm: Our patient presented a YAP1-TFE3 fusion which has been described to act as tumor-driving gene fusion in a subset of EHE (Antonescu et al. 2013; Rosenbaum et al. 2020; Szulzewsky et al. 2021).